Tuesday, November 12, 2019
Home Innovation That Matters

Innovation That Matters

Combatting the Hep B Virus: An Interview with George Hartman, Novira Therapeutics

Dr. George Hartman is the Vice-President of Chemistry and Preclinical Development and cofounder of Novira Therapeutics, a clinical stage, privately-held company that discovers and develops small molecule antiviral drugs for the treatment of chronic hepatitis B (CHB) infection.  Novira’s lead core inhibitor candidate, NVR...

Improving the Odds in Cancer With First-Time Immunotherapies

By Rich Soll, Senior Vice President, Research Service Division, WuXi AppTec (@richsollwx) With a strong belief that precision medicine is the future backbone of medicine, combined with advancements in the cancer immunotherapy field, and a unique platform, four-year-old Cambridge, Mass. biotech player Jounce Therapeutics is...

Antibodies Designed to Combat Ebola May Provide Protection from the Rare but Deadly Infection

New insights about experimental monoclonal antibody cocktails that recognize Ebola virus may soon help provide an effective treatment option.  Ebola virus disease (EVD) is a highly lethal illness in humans that is sometimes associated with bleeding. It is caused by a family of viruses...

At the Cutting Edge of R&D Enablement, the Virtual Korean Biotech Bridge Biotherapeutics Builds a Pipeline of First- and Best-In-Class Therapeutics

By Rich Soll Senior Advisor, Strategic Initiatives, WuXi AppTec (@richsollwx) and the WuXi Content Team Founded only in 2015 and currently running with merely 17 members, South Korea-based Bridge Biotherapeutics has brought two molecular compounds forward to early clinical stages, with more programs being generated in its...

Brave Science: Putting the ‘Hutzpah’ in Early-Stage Drug Discovery

By Rich Soll, SVP of Research Service Division at WuXi AppTec (@richsollwx) From developing new paradigms for early-stage drug discovery for rare and common diseases to fostering the convergence of peptide nanotechnology, and launching scientific experiments in space, Israeli biochemist Ehud Gazit is wearing many hats these days. In...

SUBSCRIBE TO OUR NEWSLETTER

SPOTLIGHT

STAY CONNECTED

Twitter LinkedIn 

WUXI NEWS

Dr. Ge Li Awarded “CEO of the Year” at CPhI Worldwide...

November 11, 2019: WuXi AppTec, a leading global provider of R&D and manufacturing services enabling companies in the pharmaceutical, biotechnology and...